Skip to main content
logo
Abbott Laboratories logo
Abbott Laboratories (ABT)
NYSE: ABT · Real-Time Price · USD
99.60
+1.11 (1.13%)
At close: Oct 9, 2026, 4:00 PM EDT
99.70
+0.10 (0.10%)
After-hours: Oct 9, 2026, 7:59 PM EDT

Abbott Laboratories Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Quarter
CurrentQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Oct '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Market Capitalization
172,346158,052178,816217,859233,117236,635230,058196,184198,366180,765197,221191,088168,069189,580175,984191,427169,448190,240208,726241,365209,423
Market Cap Growth (YoY)
-26.25%-33.21%-22.27%11.05%17.52%30.91%16.65%2.67%18.03%-4.65%12.07%-0.18%-0.81%-0.35%-15.69%-20.69%-19.09%-7.65%-1.68%28.66%8.69%
Enterprise Value
199,463185,533184,654223,411239,569243,334237,653203,674206,234189,052206,039199,953177,132197,296183,979198,309177,225199,436217,950250,286219,209
Last Close Price
99.6090.10101.31123.00130.91132.34128.48108.98109.3399.12107.89103.9890.99101.9394.20101.6889.1999.71108.19128.19107.18

Price Ratios

Fiscal Quarter
CurrentQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Oct '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
PE Ratio
32.2329.2628.6033.5216.6816.9317.0414.6434.4332.5935.1733.5232.6936.8830.4227.7221.5722.3327.1334.2829.04
Forward PE
17.1916.2118.7822.6324.7725.7725.7622.3923.1621.8024.6024.2221.5824.6423.0226.6423.7525.4324.4630.0528.18
PS Ratio
3.703.393.964.925.325.495.434.684.814.444.894.764.214.714.244.393.764.184.695.604.95
PB Ratio
3.373.053.394.134.554.664.694.104.964.575.054.924.465.074.735.194.725.185.866.706.05
P/TBV Ratio
---9.6510.9011.4411.9910.9622.5822.0927.6631.2834.1546.4443.1755.7666.6988.32---
P/FCF Ratio
22.0320.2024.2429.4633.7034.9334.5630.8930.5831.9740.0637.7737.4234.5425.7924.5319.8422.4725.6027.9122.49
P/OCF Ratio
17.4015.9618.8922.7725.5626.1925.7122.9222.7322.8827.6126.3225.6625.4420.3219.9816.4218.5720.9522.9218.59
PEG Ratio
1.871.751.872.352.582.782.552.612.742.843.082.852.943.212.975.164.193.882.642.382.09

EV Ratios

Fiscal Quarter
CurrentQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Oct '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
EV/Sales Ratio
4.283.984.095.045.465.655.614.865.004.645.114.994.434.914.434.543.944.384.905.815.18
EV/EBITDA Ratio
17.0816.1615.9918.8820.7421.4421.6319.0119.2918.0319.9119.1117.6119.4316.7516.0212.9713.8215.6118.9016.92
EV/EBIT Ratio
24.2223.0822.0325.6228.4629.6530.4027.1727.6326.1128.9827.6925.9628.4923.8021.7617.1818.0320.6825.8023.24
EV/FCF Ratio
25.4923.7125.0330.2134.6435.9235.7032.0731.8033.4441.8539.5239.4335.9526.9725.4120.7523.5526.7428.9423.54

Financial Efficiency

Fiscal Quarter
CurrentQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Oct '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Debt / Equity Ratio
0.630.630.650.270.250.270.270.320.380.380.380.410.420.450.460.490.460.460.480.530.53
Debt / EBITDA Ratio
2.712.813.701.051.081.131.281.251.351.421.581.311.511.711.751.701.541.271.121.231.33
Debt / FCF Ratio
4.184.184.631.911.881.992.002.412.322.632.993.163.503.102.502.301.941.992.102.231.98
Net Debt / Equity Ratio
0.520.520.510.100.100.120.130.150.180.190.210.220.230.240.200.210.190.210.250.250.25
Net Debt / EBITDA Ratio
2.322.362.320.440.450.550.590.690.680.730.780.830.860.870.680.630.490.520.640.680.67
Net Debt / FCF Ratio
3.473.473.640.700.760.910.971.161.121.351.641.721.931.611.101.000.780.891.101.040.94
Asset Turnover
0.460.450.540.540.540.510.560.580.570.550.560.560.540.530.550.570.610.640.620.59
Inventory Turnover
2.822.982.902.982.972.862.793.002.762.702.672.722.732.652.703.053.183.413.683.313.31
Quick Ratio
0.800.800.841.021.091.141.091.051.001.020.951.001.041.001.071.061.221.331.211.281.25
Current Ratio
1.381.381.391.581.701.821.781.671.601.681.601.641.741.641.681.631.862.011.851.851.83
Return on Equity (ROE)
7.11%8.17%13.66%12.88%14.25%10.93%83.97%16.55%13.25%12.58%16.66%15.30%14.74%14.22%11.35%15.81%22.31%27.32%22.52%24.47%
Return on Assets (ROA)
4.22%3.81%7.25%6.55%6.64%5.65%6.98%6.77%6.21%5.21%7.38%6.08%5.70%5.49%5.94%6.37%8.37%10.09%9.91%8.89%
Return on Invested Capital (ROIC)
1.42%1.63%3.26%2.93%3.23%2.48%4.24%3.58%3.11%2.74%4.06%3.28%3.10%3.07%3.14%3.52%4.79%5.72%5.71%5.07%
Return on Capital Employed (ROCE)
9.00%8.80%9.10%12.40%12.10%11.60%11.40%11.10%12.60%12.20%12.20%12.20%11.60%11.70%13.00%15.50%17.40%17.90%17.20%15.60%15.50%

Yields

Fiscal Quarter
CurrentQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Oct '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Earnings Yield
3.13%3.43%3.51%3.00%6.00%5.91%5.87%6.83%2.91%3.07%2.85%3.00%3.07%2.72%3.30%3.62%4.66%4.50%3.70%2.93%3.46%
FCF Yield
4.54%4.95%4.13%3.39%2.97%2.86%2.89%3.24%3.27%3.13%2.50%2.65%2.67%2.90%3.88%4.08%5.04%4.45%3.91%3.58%4.45%
Dividend Yield
2.53%2.75%2.41%1.95%1.80%1.75%1.77%2.05%2.01%2.18%1.97%2.00%2.24%1.96%2.08%1.89%2.11%1.86%1.70%1.42%1.68%
Payout Ratio
81.54%118.75%101.95%57.99%62.71%57.84%77.43%10.38%58.32%73.81%78.12%55.71%61.84%64.73%67.53%79.67%57.56%41.03%34.00%40.12%38.14%
Buyback Yield / Dilution
0.08%0.45%0.01%-0.06%-0.10%0.02%0.14%0.11%0.04%-0.07%0.12%0.34%0.87%0.88%1.28%1.57%1.42%1.55%0.95%0.39%-0.06%
Total Shareholder Return
2.61%3.20%2.42%1.89%1.70%1.77%1.91%2.17%2.05%2.11%2.08%2.34%3.11%2.84%3.36%3.46%3.52%3.42%2.65%1.81%1.62%
SEC Filings: 10-K · 10-Q